Transplanted patient‐derived tumor cells were identified using human‐specific probes/antibodies and enriched in the CD45dim/CD38+/CD56+/CD19‐/CD27+/CD138+or−/cLambda−/cKappa+ myeloma cell population (Supplemental Figure S5). The gene discussed is NCAM1; the disease is plasma cell myeloma.